Literature DB >> 14502062

Ototoxicity: bioprotective mechanisms.

Leonard P Rybak1, Thomas Kelly.   

Abstract

PURPOSE OF REVIEW: This review discusses current research dealing with novel approaches to the prevention of ototoxicity caused by cisplatin and aminoglycoside antibiotics. RECENT
FINDINGS: The ototoxic mechanisms of both classes of drugs appear to involve the production of reactive oxygen species. Strategies to prevent ototoxicity have involved the administration of free-radical scavengers, iron chelators, and inhibitors of cell death pathways. The potential for interference with the desired therapeutic effects of cisplatin and aminoglycoside antibiotics is examined in many of the investigations that are described.
SUMMARY: These findings provide the potential for exciting clinical trials to determine whether the animal experiments can be translated into rational therapeutic approaches to the problem of ototoxicity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14502062     DOI: 10.1097/00020840-200310000-00004

Source DB:  PubMed          Journal:  Curr Opin Otolaryngol Head Neck Surg        ISSN: 1068-9508            Impact factor:   2.064


  19 in total

1.  The protective effect of erdosteine against ototoxicity induced by cisplatin in rats.

Authors:  M Tayyar Kalcioglu; Ahmet Kizilay; Mukaddes Gulec; Erkan Karatas; Mustafa Iraz; Omer Akyol; Mucahit Egri; Orhan Ozturan
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-03-02       Impact factor: 2.503

Review 2.  Intracochlear drug delivery systems.

Authors:  Jeffrey T Borenstein
Journal:  Expert Opin Drug Deliv       Date:  2011-05-26       Impact factor: 6.648

3.  Systemic application of honokiol prevents cisplatin ototoxicity without compromising its antitumor effect.

Authors:  Xiaodong Tan; Yingjie Zhou; Aditi Agarwal; Michelle Lim; Yingyue Xu; Yueming Zhu; Joseph O'Brien; Elizabeth Tran; Jing Zheng; David Gius; Claus-Peter Richter
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

Review 4.  Adverse effects of a single dose of gentamicin in adults: a systematic review.

Authors:  Rachel S Hayward; Jan Harding; Rob Molloy; Lucy Land; Kate Longcroft-Neal; David Moore; Jonathan D C Ross
Journal:  Br J Clin Pharmacol       Date:  2017-11-03       Impact factor: 4.335

5.  TRPV1 regulators mediate gentamicin penetration of cultured kidney cells.

Authors:  Sigrid E Myrdal; Peter S Steyger
Journal:  Hear Res       Date:  2005-06       Impact factor: 3.208

6.  Short interfering RNA against transient receptor potential vanilloid 1 attenuates cisplatin-induced hearing loss in the rat.

Authors:  Debashree Mukherjea; Sarvesh Jajoo; Craig Whitworth; Jennifer R Bunch; Jeremy G Turner; Leonard P Rybak; Vickram Ramkumar
Journal:  J Neurosci       Date:  2008-12-03       Impact factor: 6.167

7.  Protective effect of metformin against cisplatin-induced ototoxicity in an auditory cell line.

Authors:  Jiwon Chang; Hak Hyun Jung; Ji Yoon Yang; Sehee Lee; June Choi; Gi Jung Im; Sung Won Chae
Journal:  J Assoc Res Otolaryngol       Date:  2013-12-03

8.  Cisplatin-induced hair cell death requires STAT1 and is attenuated by epigallocatechin gallate.

Authors:  Nicole C Schmitt; Edwin W Rubel; Neil M Nathanson
Journal:  J Neurosci       Date:  2009-03-25       Impact factor: 6.167

9.  Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach.

Authors:  R Stephanie Huang; Shiwei Duan; Sunita J Shukla; Emily O Kistner; Tyson A Clark; Tina X Chen; Anthony C Schweitzer; John E Blume; M Eileen Dolan
Journal:  Am J Hum Genet       Date:  2007-08-01       Impact factor: 11.025

10.  Assessment of nutrient supplement to reduce gentamicin-induced ototoxicity.

Authors:  C G Le Prell; C Ojano-Dirain; E W Rudnick; M A Nelson; S J DeRemer; D M Prieskorn; J M Miller
Journal:  J Assoc Res Otolaryngol       Date:  2014-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.